Live Breaking News & Updates on China alliance for rare disease

Stay updated with breaking news from China alliance for rare disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CANbridge doses first subject in Phase I/II Gaucher disease therapy trial

CANbridge doses first subject in Phase I/II Gaucher disease therapy trial
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

China , Beijing , Peking , James-xue , China-alliance-for-rare-disease , Contract-research-organisation-for-clinical-trials , Saas-platform-decentralizing-clinical-research-at-scale , Union-medical-college-hospital , Canbridge-pharmaceuticals , National-collaborative-network-for-the-diagnosis , Wuxi-biologics , China-alliance

CANbridge Pharmaceuticals CEO, James Xue, Named as Termeer Foundation Mentor

To Provide Mentoring to Emerging Life Science Leaders in Rare Disease Support Termeer Foundation's Mission of Connecting Leaders to Catalyze New Treatments ...

China , Shanghai , Peking , Beijing , Michigan , United-states , Linkedin-termeerfoundation , James-xue , Henri-termeer , Belinda-termeer , China-alliance-for-rare-disease , Research-development-association